WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Description

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

Conditions

Stroke, Acute

Talk to us

Study Overview

On this page

Study Details

Study overview

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Condition
Stroke, Acute
Intervention / Treatment

-

Contacts and Locations

Jacksonville

Baptist Medical Center, Jacksonville, Florida, United States, 32207

Atlanta

Grady Memorial Hospital/Emory University, Atlanta, Georgia, United States, 30303

The Bronx

Montefiore Medical Center, The Bronx, New York, United States, 10467

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subject is 18 years of age or older, or of legal age to give informed consent per state or national law.
  • * Baseline NIHSS score obtained prior to randomization must be equal or higher than 10 points.
  • * Subjects with no significant pre-stroke functional disability (modified Rankin scale 0 - 2).
  • * Subjects suspected of acute ischemic stroke with an estimated arrival time at a stroke center (clinical investigational site participating in this study) \< 6 hours from symptom onset. Symptom onset is defined as point in time the patient was last known well (at baseline).
  • * Informed consent obtained from patient or his or her legally designated representative (if locally required).
  • * Angiography suite immediately available.
  • * Endovascular treatment team immediately available (Neurologist, Neurointerventionist, Anesthesiologist, Nursing, Technicians as per local standard practice)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Philips Clinical & Medical Affairs Global,

Raul G Nogueira, PRINCIPAL_INVESTIGATOR, UPMC Stroke Institute, Pittsburgh

Marc Ribo, PRINCIPAL_INVESTIGATOR, Vall d'Hebron University Hospital, Barcelona

Study Record Dates

2025-12-01